CONMED CORP (CNMD) Stock Fundamental Analysis
NYSE:CNMD - US2074101013 - Common Stock
54.38 USD
-0.35 (-0.64%)
Overall CNMD gets a fundamental rating of 6 out of 10. We evaluated CNMD against 185 industry peers in the Health Care Equipment & Supplies industry. While CNMD has a great profitability rating, there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on CNMD. With these ratings, CNMD could be worth investigating further for value investing!.
1. Profitability
1.1 Basic Checks
In the past year CNMD was profitable.
CNMD had a positive operating cash flow in the past year.
Of the past 5 years CNMD 4 years were profitable.
CNMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With an excellent Return On Assets value of 4.73%, CNMD belongs to the best of the industry, outperforming 81.08% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.99%, CNMD belongs to the top of the industry, outperforming 85.41% of the companies in the same industry.
The Return On Invested Capital of CNMD (7.55%) is better than 83.24% of its industry peers.
CNMD had an Average Return On Invested Capital over the past 3 years of 5.34%. This is below the industry average of 8.44%.
The last Return On Invested Capital (7.55%) for CNMD is above the 3 year average (5.34%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.73% | ||
| ROE | 10.99% | ||
| ROIC | 7.55% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
1.3 Margins
With a decent Profit Margin value of 8.31%, CNMD is doing good in the industry, outperforming 80.00% of the companies in the same industry.
CNMD's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 14.38%, CNMD belongs to the best of the industry, outperforming 82.70% of the companies in the same industry.
In the last couple of years the Operating Margin of CNMD has grown nicely.
Looking at the Gross Margin, with a value of 56.05%, CNMD is in line with its industry, outperforming 51.89% of the companies in the same industry.
CNMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.38% | ||
| PM (TTM) | 8.31% | ||
| GM | 56.05% |
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
2. Health
2.1 Basic Checks
CNMD has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
CNMD has more shares outstanding than it did 1 year ago.
CNMD has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CNMD has an improved debt to assets ratio.
2.2 Solvency
CNMD has an Altman-Z score of 2.14. This is not the best score and indicates that CNMD is in the grey zone with still only limited risk for bankruptcy at the moment.
CNMD has a better Altman-Z score (2.14) than 62.70% of its industry peers.
CNMD has a debt to FCF ratio of 5.95. This is a neutral value as CNMD would need 5.95 years to pay back of all of its debts.
The Debt to FCF ratio of CNMD (5.95) is better than 78.38% of its industry peers.
CNMD has a Debt/Equity ratio of 0.88. This is a neutral value indicating CNMD is somewhat dependend on debt financing.
CNMD has a worse Debt to Equity ratio (0.88) than 77.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 5.95 | ||
| Altman-Z | 2.14 |
ROIC/WACC1.12
WACC6.73%
2.3 Liquidity
CNMD has a Current Ratio of 2.23. This indicates that CNMD is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.23, CNMD perfoms like the industry average, outperforming 41.08% of the companies in the same industry.
CNMD has a Quick Ratio of 1.00. This is a normal value and indicates that CNMD is financially healthy and should not expect problems in meeting its short term obligations.
CNMD has a worse Quick ratio (1.00) than 76.22% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.23 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
CNMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.38%, which is quite impressive.
The Earnings Per Share has been growing by 9.44% on average over the past years. This is quite good.
Looking at the last year, CNMD shows a small growth in Revenue. The Revenue has grown by 3.94% in the last year.
CNMD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.47% yearly.
EPS 1Y (TTM)20.38%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%17.35%
Revenue 1Y (TTM)3.94%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%3.09%
3.2 Future
The Earnings Per Share is expected to grow by 9.42% on average over the next years. This is quite good.
CNMD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.42% yearly.
EPS Next Y9.58%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
EPS Next 5YN/A
Revenue Next Year5.05%
Revenue Next 2Y5.25%
Revenue Next 3Y5.42%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 12.11, CNMD is valued correctly.
CNMD's Price/Earnings ratio is rather cheap when compared to the industry. CNMD is cheaper than 90.27% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.08. CNMD is valued rather cheaply when compared to this.
CNMD is valuated reasonably with a Price/Forward Earnings ratio of 11.18.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CNMD indicates a rather cheap valuation: CNMD is cheaper than 91.35% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CNMD to the average of the S&P500 Index (22.67), we can say CNMD is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.11 | ||
| Fwd PE | 11.18 |
4.2 Price Multiples
92.43% of the companies in the same industry are more expensive than CNMD, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNMD indicates a rather cheap valuation: CNMD is cheaper than 96.22% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.35 | ||
| EV/EBITDA | 9.64 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
CNMD has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.26
PEG (5Y)1.28
EPS Next 2Y8.14%
EPS Next 3Y9.42%
5. Dividend
5.1 Amount
CNMD has a Yearly Dividend Yield of 1.51%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 1.74, CNMD pays a better dividend. On top of this CNMD pays more dividend than 95.14% of the companies listed in the same industry.
Compared to the average S&P500 Dividend Yield of 2.34, CNMD is paying slightly less dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.51% |
5.2 History
The dividend of CNMD decreases each year by -0.01%.
CNMD has paid a dividend for at least 10 years, which is a reliable track record.
CNMD has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)-0.01%
Div Incr Years0
Div Non Decr Years12
5.3 Sustainability
CNMD pays out 22.42% of its income as dividend. This is a sustainable payout ratio.
DP22.42%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
NYSE:CNMD (8/27/2025, 10:45:57 AM)
54.38
-0.35 (-0.64%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners116.94%
Inst Owner Change-1.49%
Ins Owners0.28%
Ins Owner Change-0.1%
Market Cap1.68B
Analysts73.33
Price Target62.99 (15.83%)
Short Float %6.81%
Short Ratio4.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.51% |
Yearly Dividend0.8
Dividend Growth(5Y)-0.01%
DP22.42%
Div Incr Years0
Div Non Decr Years12
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.57%
Min EPS beat(2)0.37%
Max EPS beat(2)14.78%
EPS beat(4)4
Avg EPS beat(4)7%
Min EPS beat(4)0.37%
Max EPS beat(4)14.78%
EPS beat(8)7
Avg EPS beat(8)4.79%
EPS beat(12)10
Avg EPS beat(12)-0.43%
EPS beat(16)13
Avg EPS beat(16)0.77%
Revenue beat(2)1
Avg Revenue beat(2)-0.12%
Min Revenue beat(2)-0.75%
Max Revenue beat(2)0.51%
Revenue beat(4)1
Avg Revenue beat(4)-0.8%
Min Revenue beat(4)-2.4%
Max Revenue beat(4)0.51%
Revenue beat(8)1
Avg Revenue beat(8)-1.21%
Revenue beat(12)3
Avg Revenue beat(12)-1.83%
Revenue beat(16)4
Avg Revenue beat(16)-1.82%
PT rev (1m)-10.18%
PT rev (3m)-5.24%
EPS NQ rev (1m)5.71%
EPS NQ rev (3m)-2%
EPS NY rev (1m)1.69%
EPS NY rev (3m)1.38%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.56%
Revenue NY rev (1m)0.43%
Revenue NY rev (3m)0.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.11 | ||
| Fwd PE | 11.18 | ||
| P/S | 1.27 | ||
| P/FCF | 11.35 | ||
| P/OCF | 10.19 | ||
| P/B | 1.68 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.64 |
EPS(TTM)4.49
EY8.26%
EPS(NY)4.87
Fwd EY8.95%
FCF(TTM)4.79
FCFY8.81%
OCF(TTM)5.34
OCFY9.82%
SpS42.85
BVpS32.4
TBVpS-13.11
PEG (NY)1.26
PEG (5Y)1.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.73% | ||
| ROE | 10.99% | ||
| ROCE | 9.38% | ||
| ROIC | 7.55% | ||
| ROICexc | 7.68% | ||
| ROICexgc | 25.98% | ||
| OM | 14.38% | ||
| PM (TTM) | 8.31% | ||
| GM | 56.05% | ||
| FCFM | 11.18% |
ROA(3y)1.68%
ROA(5y)1.82%
ROE(3y)3.56%
ROE(5y)3.99%
ROIC(3y)5.34%
ROIC(5y)4.97%
ROICexc(3y)5.41%
ROICexc(5y)5.04%
ROICexgc(3y)20.03%
ROICexgc(5y)18.26%
ROCE(3y)6.64%
ROCE(5y)6.18%
ROICexcg growth 3Y14.62%
ROICexcg growth 5Y8.81%
ROICexc growth 3Y13.67%
ROICexc growth 5Y10.96%
OM growth 3Y13.68%
OM growth 5Y9.55%
PM growth 3Y17.89%
PM growth 5Y27.61%
GM growth 3Y-0.07%
GM growth 5Y0.25%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.88 | ||
| Debt/FCF | 5.95 | ||
| Debt/EBITDA | 3.34 | ||
| Cap/Depr | 23.31% | ||
| Cap/Sales | 1.28% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.68% | ||
| Profit Quality | 134.53% | ||
| Current Ratio | 2.23 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.14 |
F-Score7
WACC6.73%
ROIC/WACC1.12
Cap/Depr(3y)25.34%
Cap/Depr(5y)23%
Cap/Sales(3y)1.54%
Cap/Sales(5y)1.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.38%
EPS 3Y9.03%
EPS 5Y9.44%
EPS Q2Q%17.35%
EPS Next Y9.58%
EPS Next 2Y8.14%
EPS Next 3Y9.42%
EPS Next 5YN/A
Revenue 1Y (TTM)3.94%
Revenue growth 3Y8.95%
Revenue growth 5Y6.47%
Sales Q2Q%3.09%
Revenue Next Year5.05%
Revenue Next 2Y5.25%
Revenue Next 3Y5.42%
Revenue Next 5YN/A
EBIT growth 1Y11.97%
EBIT growth 3Y23.86%
EBIT growth 5Y16.64%
EBIT Next Year45.54%
EBIT Next 3Y17.93%
EBIT Next 5YN/A
FCF growth 1Y832.34%
FCF growth 3Y16.67%
FCF growth 5Y15.46%
OCF growth 1Y345.31%
OCF growth 3Y14.3%
OCF growth 5Y11.92%